Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
Mark T. Heise(University of North Carolina at Chapel Hill), Victoria K. Baxter(Texas Biomedical Research Institute)
Cited by 0
Related Papers
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
|Nature Communications|2024|15
A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1